Enteroscopy in small-bowel Crohn’s disease (CD): hypes and hopes

by Krisztina B. Gecse, Peter L. Lakatos
Published 2014-12-01

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease

by Che-Yung Chao, Carolyne Lemieux, Sophie Restellini, Waqqas Afif, Alain Bitton, Peter L Lakatos, Gary Wild, Talat Bessissow
Published 2019-01-01

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance F...

by Zsuzsanna Kurti, Akos Ilias, Lorant Gonczi, Zsuzsanna Vegh, Petra Fadgyas-Freyler, Gyula Korponay, Petra A. Golovics, Barbara D. Lovasz, Peter L. Lakatos
Published 2018-01-01

Does dermatitis herpetiformis result in bone loss as coeliac disease does?: a cross sectional study

by Katalin Lorinczy, Márk Juhász, Ágnes Csontos, Bálint Fekete, Orsolya Terjék, Péter L. Lakatos, Pál Miheller, Dorottya Kocsis, Sarolta Kárpáti, Zsolt Tulassay, Tamás Zágoni

Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study.

by Péter Kunovszki, Ágnes Milassin, Judit Gimesi-Országh, Péter Takács, Kata Szántó, Anita Bálint, Klaudia Farkas, András Borsi, Péter L Lakatos, Tamás Szamosi, Tamás Molnár
Published 2020-01-01

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderat...

by Heinfried H. Radeke, Jürgen Stein, Gert Van Assche, Gerhard Rogler, Peter L. Lakatos, Florian Muellershausen, Pierre Moulin, Philip Jarvis, Laurence Colin, Peter Gergely, Wolfgang Kruis
Published 2020-08-01

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

by Lorant Gonczi, Zsuzsanna Kurti, Mariann Rutka, Zsuzsanna Vegh, Klaudia Farkas, Barbara D. Lovasz, Petra A. Golovics, Krisztina B. Gecse, Balazs Szalay, Tamas Molnar, Peter L. Lakatos
Published 2017-08-01

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study

by M. Ellen Kuenzig, Jeff Yim, Stephanie Coward, Bertus Eksteen, Cynthia H. Seow, Cheryl Barnabe, Herman W. Barkema, Mark S. Silverberg, Peter L. Lakatos, Paul L. Beck, Richard Fedorak, Levinus A. Dieleman, Karen Madsen, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan
Published 2017-07-01